Ylang-Ylang

Cananga odorata contains a complex essential oil rich in caryophyllene, linalool, benzyl benzoate, and the oxoaporphine alkaloid liriodenine, which exert antimicrobial, anti-inflammatory, and cytotoxic effects through topoisomerase II inhibition and endorphin-pathway modulation. Preclinical evidence demonstrates that nerolidol isomers from its essential oil achieve a 2-log reduction in adherence by clinical strains of Staphylococcus aureus and Klebsiella pneumoniae, while liriodenine shows potent in vitro and in vivo topoisomerase II inhibitory activity, though no human clinical trials have confirmed therapeutic efficacy.

Origin & History

Cananga odorata is native to the tropical rainforests of Southeast Asia and the Pacific Islands, including the Philippines, Indonesia, Papua New Guinea, and the Comoro Islands. The tree thrives in humid, lowland tropical climates with well-drained soils, typically growing at elevations below 500 meters. It is widely cultivated commercially in Madagascar, Réunion, and the Comoros for its highly aromatic flowers used in the perfume industry, while Pacific Island communities have long utilized its leaves, bark, and flowers for traditional medicine.

Historical & Cultural Context

Cananga odorata holds deep cultural significance across Southeast Asia and the Pacific, where its flowers have been used in ceremonial garlands, bridal preparations, and ritual offerings for centuries, particularly in Filipino and Indonesian traditions where the blossoms are strewn on newlywed beds as a symbol of love and fertility. In Papua New Guinean ethnomedicine, fresh leaves are employed as a direct topical remedy for malaria, representing an antivector or symptomatic use rooted in generations of indigenous knowledge. The tree's flowers are the source of ylang-ylang essential oil, which became a cornerstone of European perfumery in the 19th century following its introduction to French Réunion, where it was incorporated into the iconic fragrance Chanel No. 5. In Ayurvedic and traditional Southeast Asian systems, various plant parts including bark, roots, and flowers have been applied to treat skin conditions, fever, asthma, and gastrointestinal complaints, reflecting the broad ethnopharmacological profile that modern phytochemistry is only beginning to investigate.

Health Benefits

- **Antimicrobial and Antibiofilm Activity**: Nerolidol isomers (cis- and trans-) present in the essential oil inhibit the adherence phase of Staphylococcus aureus and Klebsiella pneumoniae clinical strains, achieving approximately 2-log reductions in bacterial attachment in in vitro models.
- **Anti-inflammatory Effects**: Sesquiterpene hydrocarbons, including caryophyllene, interact with CB2 cannabinoid receptors to modulate inflammatory signaling cascades, contributing to the plant's traditional use for wound care and fever management.
- **Mood Enhancement and Anxiolytic Potential**: Linalool, benzene-1-methoxy-2-methyl-, and caryophyllene are recognized for their capacity to elicit endorphin release and modulate the central nervous system, supporting the aromatherapeutic use of ylang-ylang essential oil for anxiety and mood regulation.
- **Cytotoxic and Antitumor Potential**: The oxoaporphine alkaloid liriodenine acts as a potent inhibitor of topoisomerase II in both in vitro and in vivo studies, a mechanism shared with established chemotherapeutic agents, suggesting preliminary anticancer activity warranting further investigation.
- **Insect Repellent and Antivector Properties**: Essential oil constituents, including benzyl benzoate and geranyl acetate, demonstrate insect-repellent activity, supporting the traditional use of fresh leaves in Papua New Guinean communities to manage malaria by deterring vector mosquitoes.
- **Antidiabetic Activity**: Phytochemical fractions from C. odorata have shown preliminary alpha-glucosidase inhibitory activity in in vitro assays, suggesting a potential role in modulating postprandial glucose metabolism.
- **Antimelanogenesis Effects**: Compounds isolated from C. odorata, including canangone and canangaionoside, have demonstrated inhibition of melanin synthesis pathways in cell-based models, pointing to potential applications in hyperpigmentation management.

How It Works

Liriodenine, a cytotoxic oxoaporphine alkaloid isolated from C. odorata, intercalates into DNA and inhibits topoisomerase II, preventing the re-ligation of double-strand DNA breaks and ultimately triggering apoptosis in rapidly dividing cells, a mechanism confirmed in both in vitro cell lines and in vivo animal models. Caryophyllene, a bicyclic sesquiterpene constituting approximately 13.5% of the essential oil, selectively binds to CB2 cannabinoid receptors, thereby downregulating NF-κB-mediated pro-inflammatory cytokine production including TNF-α and IL-6. Linalool and benzene-1-methoxy-2-methyl- modulate GABAergic neurotransmission and stimulate endorphin release, accounting for anxiolytic and sedative properties observed in inhalation models. Nerolidol isomers disrupt bacterial membrane integrity and block surface adhesin-mediated attachment, reducing biofilm formation by clinical isolates of S. aureus and K. pneumoniae by approximately 2 orders of magnitude.

Scientific Research

The available evidence base for Cananga odorata consists predominantly of in vitro phytochemical analyses, essential oil characterization studies using GC-MS, and limited in vivo animal models, with no peer-reviewed randomized controlled trials in human populations identified to date. A 2023 sub-acute toxicity study evaluated an ethanol extract of C. odorata flowers in an animal model, though detailed results including NOAEL values and organ-specific findings have not been fully published in accessible literature. Studies on liriodenine's topoisomerase II inhibitory activity have been conducted in cancer cell line models and rodent tumor models, providing mechanistic insights but insufficient evidence to establish clinical efficacy in humans. The overall evidence quality is rated as preliminary, and translation of in vitro antimicrobial, antidiabetic, and cytotoxic findings to clinically actionable conclusions requires well-designed human trials.

Clinical Summary

No human clinical trials meeting standard criteria for pharmacological intervention studies have been identified for Cananga odorata as a therapeutic agent. The body of research consists of in vitro bioassays and animal experiments that establish plausible mechanisms but do not provide effect sizes, confidence intervals, or human-relevant dosing data. Traditional use documentation, particularly the Papua New Guinean practice of massaging fresh leaves onto the skin for malaria, represents ethnopharmacological evidence that has not yet been validated through controlled ethnobotanical trials or pharmacokinetic studies. Confidence in therapeutic outcomes remains low due to the absence of Phase I or Phase II clinical data, and all reported benefits should be interpreted within the context of preclinical research only.

Nutritional Profile

Cananga odorata is not consumed as a food source and therefore does not provide meaningful macronutrient or micronutrient content in dietary quantities. The plant's pharmacological relevance derives from its essential oil and secondary metabolite profile: the essential oil is composed of approximately 42.3% sesquiterpene hydrocarbons (notably caryophyllene at ~13.5% and α-muurolene at ~8.4%), 18.1% monoterpene hydrocarbons, and significant phenylpropanoid fractions including benzene-1-methoxy-2-methyl- (~28.7%), linalool (~6.4%), benzyl benzoate, benzyl acetate, methyl benzoate, and geranyl acetate. Alkaloids including liriodenine, cananodine, and novel compounds canangone and canangaionoside are present in leaf and bark fractions at trace concentrations that vary with geographic origin, plant part, and extraction methodology. Bioavailability of essential oil constituents via inhalation is rapid due to pulmonary absorption, while dermal penetration varies by molecular size and lipophilicity; oral bioavailability data for isolated constituents from C. odorata specifically are not established.

Preparation & Dosage

- **Fresh Leaf Topical Application (Traditional)**: Fresh leaves are bruised or crushed and massaged directly onto the skin; this Papua New Guinean practice targets malaria and is undosed in the clinical literature, with no standardized protocol established.
- **Essential Oil (Aromatherapy)**: Typically diluted to 1–3% in a carrier oil for topical application or used in a diffuser at 3–5 drops per 100 mL of water; no therapeutic dose has been established in clinical trials.
- **Ethanolic Flower Extract (Research Grade)**: Used in preclinical studies; extraction typically employs 70–95% ethanol at room temperature for 24–72 hours with subsequent filtration and evaporation; no human dose established.
- **Methanolic Leaf and Flower Bud Extract**: Employed in in vitro antimicrobial and cytotoxicity assays; minimum inhibitory concentrations vary by target organism and have not been translated to oral supplemental doses.
- **Steam-Distilled Essential Oil (Commercial)**: Sold as grade Extra, I, II, or III based on distillation fraction; standardization for therapeutic use is not currently defined by any pharmacopoeial monograph.
- **Note**: No evidence-based supplemental dosage range exists for any oral, topical, or inhalation form of C. odorata; all preparation methods described reflect research or traditional contexts only.

Synergy & Pairings

Caryophyllene in ylang-ylang essential oil acts synergistically with other CB2 agonists such as beta-caryophyllene-rich black pepper (Piper nigrum) extract, potentially amplifying anti-inflammatory effects through additive receptor occupancy at CB2 sites. Linalool-containing preparations may exhibit enhanced anxiolytic activity when combined with other GABAergic botanicals such as lavender (Lavandula angustifolia) or passionflower (Passiflora incarnata), as convergent modulation of GABAergic neurotransmission may produce additive sedative and anxiolytic outcomes. In traditional Pacific Island practices, fresh C. odorata leaves are often used alongside other aromatic plant remedies as part of composite topical formulations, suggesting empirical recognition of multi-herb synergy, though no mechanistic or clinical data exist to quantify these interactions.

Safety & Interactions

Cananga odorata essential oil is generally regarded as safe for use in cosmetics and fragrances at low concentrations (typically below 1–2%), but it is a recognized sensitizer; the International Fragrance Association has set use restrictions due to its capacity to cause allergic contact dermatitis, particularly from constituents such as isoeugenol and benzyl benzoate. A 2023 sub-acute toxicity study on an ethanol flower extract in an animal model was identified in the literature, but detailed NOAEL values, organ toxicity data, and maximum tolerated dose findings have not been made publicly available in accessible peer-reviewed form. No formal drug interaction studies have been conducted; however, the sedative and GABAergic properties of linalool suggest theoretical additive effects with CNS depressants including benzodiazepines, barbiturates, and opioids when inhaled in high concentrations. Cananga odorata preparations are not recommended during pregnancy or lactation due to insufficient safety data, and topical use on broken or inflamed skin should be avoided given the sensitization potential of its phenylpropanoid constituents.